Novo Nordisk
NVO
#70
Rank
C$319.30 B
Marketcap
C$71.86
Share price
1.84%
Change (1 day)
-41.81%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): C$29.32 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are C$47.21 Billion. In 2024 the company made an earning of C$25.87 Billion, an increase over its 2023 earnings that were of C$21.06 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$29.32 B13.33%
2024 C$25.87 B22.84%
2023 C$21.06 B57.81%
2022 C$13.34 B5.24%
2021 C$12.68 B12.38%
2020 C$11.28 B13.11%
2019 C$9.97 B-3.45%
2018 C$10.33 B1.88%
2017 C$10.14 B4.3%
2016 C$9.72 B10.32%
2015 C$8.81 B7.47%
2014 C$8.20 B3.4%
2013 C$7.93 B19.09%
2012 C$6.66 B15.58%
2011 C$5.76 B16.58%
2010 C$4.94 B25.66%
2009 C$3.93 B10.68%
2008 C$3.55 B55.82%
2007 C$2.28 B7.02%
2006 C$2.13 B19.05%
2005 C$1.79 B10.55%
2004 C$1.61 B
2002 C$1.12 B-14.39%
2001 C$1.31 B-52.82%
2000 C$2.79 B250%
1999 C$0.79 B31.21%
1998 C$0.60 B34.31%
1997 C$0.45 B11.46%
1996 C$0.40 B9.03%
1995 C$0.37 B-3.15%
1994 C$0.38 B-0.67%
1993 C$0.38 B45.38%
1992 C$0.26 B-13.81%
1991 C$0.30 B37.12%
1990 C$0.22 B-0.79%
1989 C$0.22 B26.2%
1988 C$0.18 B24.97%
1987 C$0.14 B-0.9%
1986 C$0.14 B-7.78%
1985 C$0.15 B24.87%
1984 C$0.12 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$16.20 B-43.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$30.76 B 7.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$10.98 B-61.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.44 B-56.34%๐Ÿ‡ซ๐Ÿ‡ท France